About SynThera Biomedical
SynThera Biomedical is a Healthcare company based in Pune (India) founded in 2015 by Nilay Lakhkar. Glass-based biomaterials for biomedical applications are manufactured. SynThera Biomedical has raised $406.24 thousand across 3 funding rounds from investors including Italica, 1Crowd and United Capital PLC Group. SynThera Biomedical was last valued at $1.36 million in April 2018. Its chief executive, as recorded, is Nilay Lakhkar. Its Indian entity Synthera Biomedical Private Limited reported revenue of ₹1.5 Lakh. SynThera Biomedical offers products and services including Porosyn, Therasenz, Bioactive Glass Powder, and Frit and Cullet. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies.
Company details
SynThera Biomedical was established in 2015 in Pune, India. Bio-active glass and ceramic products are developed, manufactured, and commercialized for healthcare and related sectors. Silicate- or phosphate-based materials are applied in dental, maxillofacial, and orthopedic bone substitutes, tissue engineering scaffolds, and antimicrobial ion delivery systems. Operations focus on specialty biomaterials for various biomedical uses.
- Headquarters Pune, India
- Founders Nilay Lakhkar
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Website synthera.in
- Social Instagram
- Legal Name Synthera Biomedical Private Limited
- Date of Incorporation 19 Jun, 2015
- Jurisdiction Pune, Maharashtra, India
- Annual Revenue₹1.5 Lakh
FY 2025 · +383% YoY
- Net Loss-₹97 Lakh
FY 2025 · -6348% margin
- EBITDA-₹81.6 Lakh
FY 2025 · -5339% margin
- Total Equity Funding$406.24K (USD)
in 3 rounds
- Latest Funding Round$101.24K (USD), Seed
Nov 2021
- InvestorsItalica
& 32 more
Associated legal entities of SynThera Biomedical
SynThera Biomedical operates through Synthera Biomedical Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Synthera Biomedical Private Limited CIN U33111PN2015PTC155498 | Active | 19 Jun 2015 | Pune, Maharashtra | ₹0.0 Cr | 3 | View details |
Products & Services of SynThera Biomedical
SynThera Biomedical offers a comprehensive portfolio of products and services, including Porosyn, Therasenz, Bioactive Glass Powder, and Frit and Cullet.
Optimizes tissue repair and bone regeneration for medical use
Facilitates healing in dental and fracture repair applications
Provides customized powders for pharmaceutical and cosmetic needs
Offers high-purity materials for industrial and medical processing
Funding Insights of SynThera Biomedical
SynThera Biomedical has successfully raised a total of $406.24K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $101.24 thousand completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $406,239
- Total Rounds 3
- Last Round Seed — $101,242
- Investors Count 33
All 3 funding rounds of SynThera Biomedical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2021 | $101,242 | Seed | – | IKP Knowledge Park | – |
| Apr 2018 | $304,997 | Seed | $1.36M | Venture Center | |
| Jan 2018 | Seed | – | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Apr 2018 | $1.36M | •••••••• |
Last known valuation $1.36M (Apr 2018). 33 investors in total: 9 institutional and 24 angel.
Investors in SynThera Biomedical
SynThera Biomedical has secured backing from 33 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Italica, 1Crowd and United Capital PLC Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Med-tech startups are incubated by IKP Knowledge Park. | 1999 | ikpknowledgepark.com | Hyderabad, India | |
Business incubation services are provided across multiple sectors. | birac.nic.in | Delhi, India | ||
Startups are incubated at Venture Center, backed by CSIR. | venturecenter.co.in | Pune, India | ||
Early-stage venture capital investment firm | 2015 | 1crowd.co | Mumbai, India | |
Supplying steel and energy raw materials through commodity trading, mining, and green investing. | enrsingapore.com | |||
Italica is engaged in manufacturing and selling plastic furniture. | 1992 | italica.com | Mumbai, India | |
Limited information available | 2012 | unitedcapitalclub.com | Delhi, India | |
Offers stylish wardrobes and hotel solutions with sustainable design practices. | 2016 | italica-furniture.com | Dubai, United Arab Emirates | |
Investment holding company | 1964 | unitedcapitalplcgroup.com | Lagos, Nigeria | |
AJ Anand Janardan Lamdhade | unknown_bb6ec5d491f64357a |
Investor details for SynThera Biomedical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Synthera Biomedical Private Limited (SynThera Biomedical)
Synthera Biomedical Private Limited is the primary company behind SynThera Biomedical. The board of Synthera Biomedical Private Limited currently have 3 directors; the longest-serving is Nilay Jayant Lakhkar, appointed in 2015. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nilay Jayant Lakhkar DIN 07163423 | Director | 19 Jun 2015 | 11 yrs 4 mo | Synthera Biomedical Private Limited |
| Jayant Anand Lakhkar DIN 07163400 | Director | 19 Jun 2015 | 11 yrs 4 mo | Synthera Biomedical Private Limited |
| Natasha Dipen Kothari DIN 07146608 | Nominee Director | 15 Jun 2018 | 8 yrs 4 mo | Synthera Biomedical Private Limited |
People of SynThera Biomedical
1 people are tracked at SynThera Biomedical (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder & CEO | Leadership |
Complete people profiles for SynThera Biomedical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of SynThera Biomedical
Figures of Synthera Biomedical Private Limited, the primary company behind SynThera Biomedical, for FY 2025. Revenue was ₹1.5 Lakh (+383% year on year). Net loss was -₹97 Lakh (-6348% margin). EBITDA was -₹81.6 Lakh (-5339% margin). Revenue has grown at a compounded annual rate of -66% over three years and -35% over five years.
- ₹1.5 LakhRevenue · FY 2025 · +383% YoY
- -₹97 LakhNet loss · -6348% margin
- -₹81.6 LakhEBITDA · -5339% margin
- ₹1.4 LakhPaid-up capital
- -66%Revenue CAGR, 3 years
- -35%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Synthera Biomedical Private Limited are on its company page.
Detailed financial statements for SynThera Biomedical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of SynThera Biomedical
4 dated milestones of SynThera Biomedical across 6 years, from founding to its latest funding, stage changes and deals.
- Founded SynThera Biomedical is founded.
- Funding First funding round.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $101K.
Web traffic of SynThera Biomedical
The website of SynThera Biomedical (synthera.in) receives about 3.8K visits a month.
- Monthly visits3.8K
▲ 118.4% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Synthera Biomedical
Complete news archive for SynThera Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SynThera Biomedical
SynThera Biomedical was founded in 2015 and raised its 1st funding round 3 years after it was founded.
SynThera Biomedical is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Nilay Lakhkar is the CEO of SynThera Biomedical, as recorded in our data. They have also founded this company.
SynThera Biomedical is a funded company, having raised a total of $406.24K across 3 funding rounds to date.
The primary company behind SynThera Biomedical, Synthera Biomedical Private Limited, reported revenue of ₹1.5 Lakh for FY 2025, up 383% year on year.
SynThera Biomedical was established in 2015 in Pune, India. Bio-active glass and ceramic products are developed, manufactured, and commercialized for healthcare and related sectors. Silicate- or phosphate-based materials are applied in dental, maxillofacial, and orthopedic bone substitutes, tissue engineering scaffolds, and antimicrobial ion delivery systems. Operations focus on specialty biomaterials for various biomedical uses.
SynThera Biomedical offers Porosyn, Therasenz, Bioactive Glass Powder, and Frit and Cullet.
SynThera Biomedical has 33 investors. Key investors include Italica, 1Crowd, United Capital PLC Group, IKP Knowledge Park, and United Capital Club.
The valuation of SynThera Biomedical is $1.36M as of Apr 2018.
SynThera Biomedical operates through Synthera Biomedical Private Limited.
The legal entities of SynThera Biomedical currently have 3 directors, including Natasha Dipen Kothari, Nilay Jayant Lakhkar, Jayant Anand Lakhkar.